about us | leadership | team | board of directors | scientific advisors
Preclinical data on our dual ICOS/CD28 antagonist vIgD in animal model of GvHD. Poster now up at #FOCIS2017. ow.ly/RhMg30cAzNH
June 14, 2017 5:00 pm
Proud to announce merger agreement w/ $NVLS Expected to accelerate development of our #immunotherapy platform ow.ly/81MR30aXEKE
April 18, 2017 8:24 pm
© 2017 Alpine Immune Sciences. All Rights Reserved, Alpine Immune Sciences Inc.